Product Information
DROXIDOPA 200 MG CAPSULE is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $1.6733 per EA under NDC 63304010490. Its NADAC has been published 149 times since Feb 22, 2023.
FDA first approved this application on Feb 18, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
200 ug/1
Manufacturer
Sun Pharmaceutical Industries Inc.NDC
63304010490
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
2/18/2026
Active Ingredients
DROXIDOPAApproval Type
Generic (ANDA)
FDA Application
ANDA214384FDA Approved
2/18/2021
TE Code
AB
On Market Since
2/18/2021
Pharmacological Classes
Price Statistics
The NADAC for DROXIDOPA 200 MG CAPSULE has been published 149 times since Feb 22, 2023, and over the history we have for it it has declined 21.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.6733 per EA |
|---|---|
| All-time high | $2.3453 (Jul 10, 2024) |
| All-time low | $1.2814 (Apr 23, 2025) |
| 52-week high | $1.7346 |
| 52-week low | $1.5816 |
| Median price | $1.8279 |
| Average price | $1.8446 |
| Largest weekly change | -25.1% (Jul 17, 2024) |
| Weeks tracked | 149 |
| Tracking since | Feb 22, 2023 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
+0.8%
3Y
-21.4%
5Y
N/A
All
-21.4%
Last surveyed Feb 18, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 47% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DROXIDOPA 200 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for DROXIDOPA 200 MG CAPSULE, manufactured by Sun Pharmaceutical Industries Inc., is $1.6733 per EA (NDC 63304010490), effective Feb 18, 2026.
How has the price of DROXIDOPA 200 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for DROXIDOPA 200 MG CAPSULE has declined 21.4%. It has been tracked across 149 weekly CMS publications since Feb 22, 2023.
What are the highest and lowest recorded NADAC prices for DROXIDOPA 200 MG CAPSULE?
Since Feb 22, 2023, the NADAC for DROXIDOPA 200 MG CAPSULE has ranged from a low of $1.2814 (Apr 23, 2025) to a high of $2.3453 (Jul 10, 2024), with a median of $1.8279 per EA.
Are there cheaper alternatives to DROXIDOPA 200 MG CAPSULE?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DROXIDOPA 200 MG CAPSULE, is $0.8820 per EA — about 47% below DROXIDOPA 200 MG CAPSULE.
Who manufactures DROXIDOPA 200 MG CAPSULE?
DROXIDOPA 200 MG CAPSULE (NDC 63304010490) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.